Abhay Narayan Singh

Abhay Narayan Singh

Auto-generated profile, based on publicly available information

Abhay Narayan Singh

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Molecular Cell
Verified
Journal Article
Open access
BVBruno Vaz
Bruno Vaz
MPMarta Popovic
Marta Popovic
JNJoseph A. Newman
Joseph A. Newman
JFJohn Fielden
John Fielden
HAHazel Aitkenhead
Hazel Aitkenhead
KRKristijan Ramadan
Kristijan Ramadan
The cytotoxicity of DNA-protein crosslinks (DPCs) is largely ascribed to their ability to block the progression of DNA replication. DPCs frequently occur in cells, either as a consequence of metabolism or exogenous agents, but the mechanism of DPC repair is not completely understood. Here, we characterize SPRTN as a specialized DNA-dependent and DNA replication-coupled metalloprotease for DPC repair. SPRTN cleaves various DNA binding substrates during S-phase progression and thus protects proliferative cells from DPC toxicity. Ruijs-Aalfs syndrome (RJALS) patient cells with monogenic and biallelic mutations in SPRTN are hypersensitive to DPC-inducing agents due to a defect in DNA replication fork progression and the inability to eliminate DPCs. We propose that SPRTN protease represents a specialized DNA replication-coupled DPC repair pathway essential for DNA replication progression and genome stability. Defective SPRTN-dependent clearance of DPCs is the molecular mechanism underlying RJALS, and DPCs are contributing to accelerated aging and cancer.

9 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JFJohn Fielden
John Fielden
KWKatherine Wiseman
Katherine Wiseman
ITIgnacio Torrecilla
Ignacio Torrecilla
SLShudong Li
Shudong Li
SHSamuel Hume
Samuel Hume
KRKristijan Ramadan
Kristijan Ramadan
Eukaryotic topoisomerase 1 (TOP1) regulates DNA topology to ensure efficient DNA replication and transcription. TOP1 is also a major driver of endogenous genome instability, particularly when its catalytic intermediate—a covalent TOP1-DNA adduct known as a TOP1 cleavage complex (TOP1cc)—is stabilised. TOP1ccs are highly cytotoxic and a failure to resolve them underlies the pathology of neurological disorders but is also exploited in cancer therapy where TOP1ccs are the target of widely used frontline anti-cancer drugs. A critical enzyme for TOP1cc resolution is the tyrosyl-DNA phosphodiesterase (TDP1), which hydrolyses the bond that links a tyrosine in the active site of TOP1 to a 3’ phosphate group on a single-stranded (ss)DNA break. However, TDP1 can only process small peptide fragments from ssDNA ends, raising the question of how the ~90 kDa TOP1 protein is processed upstream of TDP1. Here we find that TEX264 fulfils this role by forming a complex with the p97 ATPase and the SPRTN metalloprotease. We show that TEX264 recognises both unmodified and SUMO1-modifed TOP1 and initiates TOP1cc repair by recruiting p97 and SPRTN. TEX264 localises to the nuclear periphery, associates with DNA replication forks, and counteracts TOP1ccs during DNA replication. Altogether, our study elucidates the existence of a specialised repair complex required for upstream proteolysis of TOP1ccs and their subsequent resolution.

30 April 2011 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
ASAbhay Narayan Singh
Abhay Narayan Singh
SSSushant Singh
Sushant Singh
NSNeeraj Suthar
Neeraj Suthar
VDVikash Kumar Dubey
Vikash Kumar Dubey

15 October 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ASAbhay Narayan Singh
Abhay Narayan Singh
JOJudith Oehler
Judith Oehler
ITIgnacio Torrecilla
Ignacio Torrecilla
SKSusan Kilgas
Susan Kilgas
SLShudong Li
Shudong Li
KRKristijan Ramadan
Kristijan Ramadan
The E3 ubiquitin ligase RNF8 (RING finger protein 8) is a pivotal enzyme for DNA repair. However, RNF8 hyper‐accumulation is tumour‐promoting and positively correlates with genome instability, cancer cell invasion, metastasis and poor patient prognosis. Very little is known about the mechanisms regulating RNF8 homeostasis to preserve genome stability. Here, we identify the cellular machinery, composed of the p97/VCP ubiquitin‐dependent unfoldase/segregase and the Ataxin 3 (ATX3) deubiquitinase, which together form a physical and functional complex with RNF8 to regulate its proteasome‐dependent homeostasis under physiological conditions. Under genotoxic stress, when RNF8 is rapidly recruited to sites of DNA lesions, the p97–ATX3 machinery stimulates the extraction of RNF8 from chromatin to balance DNA repair pathway choice and promote cell survival after ionising radiation (IR). Inactivation of the p97–ATX3 complex affects the non‐homologous end joining DNA repair pathway and hypersensitises human cancer cells to IR. We propose that the p97–ATX3 complex is the essential machinery for regulation of RNF8 homeostasis under both physiological and genotoxic conditions and that targeting ATX3 may be a promising strategy to radio‐sensitise BRCA‐deficient cancers.

17 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SHSwagata Halder
Swagata Halder
ITIgnacio Torrecilla
Ignacio Torrecilla
MBMartin D. Burkhalter
Martin D. Burkhalter
MPMarta Popović
Marta Popović
JFJohn Fielden
John Fielden
KRKristijan Ramadan
Kristijan Ramadan
The SPRTN metalloprotease is essential for DNA-protein crosslink (DPC) repair and DNA replication in vertebrate cells. Cells deficient in SPRTN protease exhibit DPC-induced replication stress and genome instability, manifesting as premature ageing and liver cancer. Here, we provide a body of evidence suggesting that SPRTN activates the ATR-CHK1 phosphorylation signalling cascade during physiological DNA replication by proteolysis-dependent eviction of CHK1 from replicative chromatin. During this process, SPRTN proteolyses the C-terminal/inhibitory part of CHK1, liberating N-terminal CHK1 kinase active fragments. Simultaneously, CHK1 full length and its N-terminal fragments phosphorylate SPRTN at the C-terminal regulatory domain, which stimulates SPRTN recruitment to chromatin to promote unperturbed DNA replication fork progression and DPC repair. Our data suggest that a SPRTN-CHK1 cross-activation loop plays a part in DNA replication and protection from DNA replication stress. Finally, our results with purified components of this pathway further support the proposed model of a SPRTN-CHK1 cross-activation loop.

1 March 2010 in Process Biochemistry
Verified
Journal Article
Closed access
ASAbhay Narain Singh
Abhay Narain Singh
ASAnil Kumar Shukla
Anil Kumar Shukla
MJM.V. Jagannadham
M.V. Jagannadham
VDVikash Kumar Dubey
Vikash Kumar Dubey